These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6280603)

  • 21. Relative inhibition factors--a novel approach to the assessment of antifungal antibiotics in vitro.
    Odds FC; Abbott AB
    J Antimicrob Chemother; 1984 Jan; 13(1):31-43. PubMed ID: 6698909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The postantibiotic effect of antifungal agents against common pathogenic yeasts.
    Turnidge JD; Gudmundsson S; Vogelman B; Craig WA
    J Antimicrob Chemother; 1994 Jul; 34(1):83-92. PubMed ID: 7961219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergism of amphotericin B and 5-fluorocytosine for candida species.
    Montgomerie JZ; Edwards JE; Guze LB
    J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing.
    Utz CJ; Shadomy S
    J Infect Dis; 1977 Jun; 135(6):970-4. PubMed ID: 325150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative in vitro study of amphotericin B 1 clotrimazole and 5-fluorocytosine against clinically isolated yeasts.
    Hamilton-Miller JM
    Sabouraudia; 1972 Nov; 10(3):276-83. PubMed ID: 4565443
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine.
    Strippoli V; Torosantucci A; Simonetti N
    Chemioterapia; 1984 Apr; 3(2):119-25. PubMed ID: 6398120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined activity of ketoconazole and sulphamethoxazole against Candida albicans.
    Beggs WH
    J Antimicrob Chemother; 1982 Dec; 10(6):539-41. PubMed ID: 6298174
    [No Abstract]   [Full Text] [Related]  

  • 29. [Study of the in vitro sensitivity of yeasts with the ATB-Fungus system].
    Martínez MM; Mendaza P; Daza RM; Sánchez G; Martín P; Martín JE; Portero F
    Rev Esp Quimioter; 1998 Sep; 11(3):251-3. PubMed ID: 9795312
    [No Abstract]   [Full Text] [Related]  

  • 30. Kinetic study of antifungal activity of amphotericin B, 5-fluorocytosine and ketoconazole against clinical yeast isolates using liquid-phase turbidimetry.
    Dei-Cas E; Dujardin L; Ribeiro Pinto ME; Ajana F; Fruit J; Poulain D; Camus D; Vernes A
    Mycoses; 1991; 34(3-4):167-72. PubMed ID: 1749396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ketoconazole resistance.
    Lancet; 1982 Oct; 2(8301):770-1. PubMed ID: 6125840
    [No Abstract]   [Full Text] [Related]  

  • 32. Activity of ketoconazole and its deacyl derivative against Plasmodium falciparum and Candida isolates.
    Pfaller MA; Segal JJ; Krogstad DJ
    Antimicrob Agents Chemother; 1982 Nov; 22(5):917-9. PubMed ID: 6295271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of potentially pathogenic yeastlike fungi by clotrimazole in combination with 5-fluorocytosine or amphotericin B.
    Beggs WH; Sarosi GA; Steele NM
    Antimicrob Agents Chemother; 1976 Jun; 9(6):863-5. PubMed ID: 779631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergism of polyene antibiotics with 5-fluorocytosine.
    Polak A
    Chemotherapy; 1978; 24(1):2-16. PubMed ID: 338264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of miconazole- and ketoconazole-induced release of K+ from Candida species.
    Beggs WH
    J Antimicrob Chemother; 1983 Apr; 11(4):381-3. PubMed ID: 6304001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro synergy testing of anidulafungin with fluconazole, tioconazole, 5-flucytosine and amphotericin B against some Candida spp.
    Rosato A; Piarulli M; Schiavone BI; Montagna MT; Caggiano G; Muraglia M; Carone A; Franchini C; Corbo F
    Med Chem; 2012 Jul; 8(4):690-8. PubMed ID: 22530916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.
    Doern GV; Tubert TA; Chapin K; Rinaldi MG
    J Clin Microbiol; 1986 Oct; 24(4):507-11. PubMed ID: 3533974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Concentration-contact time relationship in the effect of antimycotic drug combinations (clotrimazole, nystatin, 5-fluorocytosine) and the effect of increasing and decreasing antimycotic drug concentrations on Candida albicans].
    Rumler W; Heins S
    Mykosen; 1985 May; 28(5):251-7. PubMed ID: 3892290
    [No Abstract]   [Full Text] [Related]  

  • 39. Laboratory methods for flucytosine (5-fluorocytosine). Report of a Working Group of the British Society for Mycopathology.
    J Antimicrob Chemother; 1984 Jul; 14(1):1-8. PubMed ID: 6480540
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
    Hernández Molina JM; Llosá J; Martinez Brocal A; Ventosa A
    Mycopathologia; 1992 Apr; 118(1):15-21. PubMed ID: 1406898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.